Literature DB >> 25267902

Pharmacological interventions for paranoid personality disorder.

Birgit A Völlm1, Saeed Farooq2, Hannah Jones3, Michael Ferriter4, Simon Gibbon5, Jutta Stoffers6, Conor Duggan1, Nick Huband7, Klaus Lieb8.   

Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows: To evaluate the effects of pharmacological interventions for people with paranoid personality disorder (PPD).

Entities:  

Year:  2011        PMID： 25267902      PMCID： PMC4176679          DOI： 10.1002/14651858.CD009100

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN： 1361-6137


  23 in total

Review 1.  Methods for evaluating area-wide and organisation-based interventions in health and health care: a systematic review.

Authors:  O C Ukoumunne; M C Gulliford; S Chinn; J A Sterne; P G Burney
Journal:  Health Technol Assess       Date:  1999       Impact factor: 4.014

2.  The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance.

Authors:  J Endicott; R L Spitzer; J L Fleiss; J Cohen
Journal:  Arch Gen Psychiatry       Date:  1976-06

3.  Functional impairment in patients with schizotypal, borderline, avoidant, or obsessive-compulsive personality disorder.

Authors:  Andrew E Skodol; John G Gunderson; Thomas H McGlashan; Ingrid R Dyck; Robert L Stout; Donna S Bender; Carlos M Grilo; M Tracie Shea; Mary C Zanarini; Leslie C Morey; Charles A Sanislow; John M Oldham
Journal:  Am J Psychiatry       Date:  2002-02       Impact factor: 18.112

4.  Prevalence and correlates of personality disorder in Great Britain.

Authors:  Jeremy Coid; Min Yang; Peter Tyrer; Amanda Roberts; Simone Ullrich
Journal:  Br J Psychiatry       Date:  2006-05       Impact factor: 9.319

5.  The Social Functioning Questionnaire: a rapid and robust measure of perceived functioning.

Authors:  Peter Tyrer; Ula Nur; Mike Crawford; Saffron Karlsen; Claire McLean; Bharti Rao; Tony Johnson
Journal:  Int J Soc Psychiatry       Date:  2005-09

6.  Meta-analyses involving cross-over trials: methodological issues.

Authors:  Diana R Elbourne; Douglas G Altman; Julian P T Higgins; Francois Curtin; Helen V Worthington; Andy Vail
Journal:  Int J Epidemiol       Date:  2002-02       Impact factor: 7.196

7.  The estimation of intraclass correlation in the analysis of family data.

Authors:  A Donner; J J Koval
Journal:  Biometrics       Date:  1980-03       Impact factor: 2.571

8.  The effect of tryptophan on social interaction in everyday life: a placebo-controlled study.

Authors:  D S Moskowitz; G Pinard; D C Zuroff; L Annable; S N Young
Journal:  Neuropsychopharmacology       Date:  2001-08       Impact factor: 7.853

9.  Change in personality status in neurotic disorders.

Authors:  Helen Seivewright; Peter Tyrer; Tony Johnson
Journal:  Lancet       Date:  2002-06-29       Impact factor: 79.321

10.  Randomized controlled trial of interventions designed to reduce the risk of progression to first-episode psychosis in a clinical sample with subthreshold symptoms.

Authors:  Patrick D McGorry; Alison R Yung; Lisa J Phillips; Hok Pan Yuen; Shona Francey; Elizabeth M Cosgrave; Dominic Germano; Jenny Bravin; Tony McDonald; Alison Blair; Stephen Adlard; Henry Jackson
Journal:  Arch Gen Psychiatry       Date:  2002-10
View more
  1 in total

1.  Review of pharmacologic treatment in cluster A personality disorders.

Authors:  Jessa Koch; Taylor Modesitt; Melissa Palmer; Sarah Ward; Bobbie Martin; Robby Wyatt; Christopher Thomas
Journal:  Ment Health Clin       Date:  2016-03-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.